63 Bashford-Rogers, R.J.M. et al. (2019) Analysis of the B cell receptor repertoire in six immune-mediated diseases. Nature 574, 122–126. doi: 10.1038/s41586-019-1595-3. Soto, C. et al. (2019) High frequency of shared clonotypes in human B cell receptor repertoires. Nature 566, 398–402. doi: 10.1038/s41586-019-0934-8. Briney, B. et al. (2019) Commonality despite exceptional diversity in the baseline human antibody repertoire. Nature 566, 393–397. doi: 10.1038/s41586-019-0879-y. Kim, D. and Park, D. (2019) Deep sequencing of B cell receptor repertoire. BMB Rep. 52, 540–547. doi: 10.5483/BMBRep.2019.52.9.192. Uzzan, M. et al. (2022) Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity. Nat Med 28, 766-779. doi: 10.1038/s41591-022001680-y. Raybould, M.I.J. et al. (2021) Current strategies for detecting functional convergence across B-cell receptor repertoires. MAbs. 13, 1996732. doi: 10.1080/19420862.2021.1996732. Chen, K. et al. (2020) Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA. Nat. Rev. Immunol. 20, 427-441. doi: 10.1038/s41577-019-0261-1. Verstockt, B. et al. (2021) How do we predict a patient’s disease course and whether they will respond to specific treatments? Gastroenterology S0016-5085(21)04081-6. doi: 10.1053/j.gastro.2021.12.245. Zhao, Q. et al. (2020) CD4+ T cell activation and concomitant mTOR metabolic inhibition can ablate microbiota-specific memory cells and prevent colitis. Sci. Immunol. 5, eabc6373. doi: 10.1126/ sciimmunol.abc6373. Sartor, R.B. (2021) Targeting Adaptive Immune Responses to Human Bacterial Flagellins in Crohn’s Disease. Gastroenterology 161, 416-418. doi: 10.1053/j.gastro.2021.05.031. 60 61 62 63 64 65 66 67 68 69 Antibody signatures in IBD: developments and applications
RkJQdWJsaXNoZXIy MjY0ODMw